Bone marrow transplants are now routinely carried out worldwide to treat people with cancer and other disorders of the blood and immune system and are a prime example of a successful stem cell therapy. Stem cells from bone marrow, peripheral blood, or umbilical cord blood are used in transplantation procedures. From the first successful bone marrow transplant involving identical twins in the late 1950s to cutting edge research of today, the emphasis on quality has evolved and has led to the establishment of standards and regulations. This presentation will focus on a brief history of the development of bone marrow transplantation accreditation standards and regulations.

Presented by: Sharon Tindle, QA Manager, Bone Marrow Transplant Program

Sharon Tindle has 40 years of experience in basic laboratory research, establishment and management of two cellular therapy processing laboratories, and for the last 6 years, full-time quality assurance management of a bone marrow transplant program. She is an ASQ Certified Quality Auditor and serves as an inspector of cellular therapy processing facilities for an accreditation organization.

Date & Time: June 7th, 2016 6-9pm

Location: Songkranth Thai, 330 8th Ave, New York, NY 10001

Meeting Presentation is available here